In late April, the California Court of Appeals delivered a blow to plaintiffs who file lawsuits against medical device manufacturers based on an alleged “failure to train” physicians on how to use prescription medical devices. The decision in Glennen v. Allergan is significant because the field of available product liability claims against Class III manufacturers has narrowed considerably since 2008, when the United States Supreme Court held that lawsuits challenging the safety and efficacy of devices approved by FDA are federally preempted.
3D printers can increasingly be found in hospitals all over the world, and are especially used by build surgical models to prepare for very unusual and highly complex surgeries. Back in April, the life of […]
HS&M – The Medical Device sector (comprising medical device, medical equipment, capital equipment and medical technology companies) showed a healthy up arrow last year, with the Top 50 company revenue totaling $328B, up 10% from $299B in 2015. […]
The way healthcare in the United States is delivered, including what goods and services get paid for, is undergoing unprecedented change thanks to factors ranging from the Affordable Care Act to provider consolidation. But one […]